Drreddys Laboratories reported INR73.9B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
ANI Pharmaceuticals USD 637.11M 39.9M Sep/2026
Aurora Cannabis CAD 76.28M 28.24M Jun/2026
Bayer EUR 9.92B 121M Sep/2026
Canopy Growth CAD 98.74M 23K Jun/2026
Cipla INR 63.61B 1.3B Sep/2026
Corcept Therapeutics USD 225.75M 10.9M Sep/2026
Drreddys Laboratories INR 73.9B 431M Sep/2026
GlaxoSmithKline GBP 6.03B 227M Sep/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Novartis USD 9.88B 325M Sep/2026
Pacira USD 1.18B 995.96M Sep/2026
Phibro Animal Health USD 417.67M 1.04B Sep/2026
Prestige Brands USD 213.19M 7.06M Jun/2026
Richter Gedeon HUF 165.23B 7.35B Jun/2026
Sun Pharmaceuticals INR 122.92B 5.49B Sep/2026
Supernus Pharmaceuticals USD 1.06B 31.25M Sep/2026
Teva Pharmaceutical Industries USD 3.18B 733M Sep/2026